Aktis Oncology, Inc. (AKTS)
17.37
+0.30
(+1.76%)
USD |
NASDAQ |
Apr 02, 16:00
17.34
-0.03
(-0.17%)
Pre-Market: 20:00
Aktis Oncology Shareholders Equity (Quarterly) : 187.26M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Merck & Co., Inc. | 52.61B |
| Akari Therapeutics Plc | 28.33M |
| Alumis, Inc. | 301.30M |
| Medline, Inc. | 10.74B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 270.01M |
| Total Liabilities (Quarterly) | 82.75M |
| Debt to Equity Ratio | 0.0617 |
| Current Ratio | 7.373 |